Pharmacology Research & Perspectives

Papers
(The H4-Index of Pharmacology Research & Perspectives is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Issue Information100
Pharmacogenomics Education and Knowledge Assessment in Healthcare Curricula: A Scoping Review of the Middle East and North Africa Region91
Modeling time‐delayed concentration‐QT effects with ACT‐1014‐6470, a novel oral complement factor 5a receptor 1 (C5a1 receptor) antagonist59
Monitoring Serum Bisoprolol Concentrations in Patients With Heart Failure With Reduced Ejection Fraction: Results of a Pilot Study From Routine Health Care47
FDA regulatory considerations for oncology drug development33
Endoplasmic reticulum stress in the adipose tissue and monocyte chemoattractant protein‐1 are involved in tacrolimus‐induced diabetes mellitus32
Cross‐modal embedding integrator for disease‐gene/protein association prediction using a multi‐head attention mechanism30
A549 Alveolar Carcinoma Spheroids as a Cytotoxicity Platform for Carboxyl‐ and Amine‐Polyethylene Glycol Gold Nanoparticles28
The potencies and neurotoxicity of intrathecal levobupivacaine in a rat spinal model: Effects of concentration27
The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β‐eudesmol in human liver: Reaction phenotyping and enzyme kinetics25
Nucleoside analog GS‐441524: pharmacokinetics in different species, safety, and potential effectiveness against Covid‐1923
Synthesis of salcaprozate sodium and its significance in enhancing pancreatic kininogenase absorption performance23
Corrigendum22
21
Patient safety in home care: A multicenter cross‐sectional study about medication errors and medication management of nurses21
The blockade of the TGF‐β pathway alleviates abnormal glucose and lipid metabolism of lipodystrophy not obesity21
Role of Chinese Medicine Monomers in Dry Eye Disease: Breaking the Vicious Cycle of Inflammation21
A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C] encor19
19
Highlights of basic and clinical pharmacology from Africa19
Quantitative analysis of the UDP‐glucuronosyltransferase transcriptome in human tissues19
Safety, tolerability, and pharmacokinetics of a single ascending subcutaneous dose of GSK3772847 in healthy participants19
0.11990284919739